首页> 外文OA文献 >Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

【2h】

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

机译：Bevacizumab与Folfox-4或Xelox-2组合在一线治疗转移性结肠直肠癌患者中：Gruppo Oncologico Dell'italia Meridionale的多中心随机期II试验（Goim 2802）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Evaristo Maiello; Gabriele Di Maggio; Stefano Cordio; Saverio Cinieri; Francesco Giuliani; Salvatore Pisconti; Antonio Rinaldi; Antonio Febbraro; Tiziana Pia Latiano; Michele Aieta; Antonio Rossi; Daniele Rizzi; Massimo Di Maio; Giuseppe Colucci; Roberto Bordonaro;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. BEVACIZUMAB + FOLFIRI AS FIRST-LINE TREATMENT IN ADVANCED COLORECTAL CANCER (ACC): A MULTICENTER PHASE II STUDY OF THE GRUPPO ONCOLOGICO DELL' ITALIA MERIDIONALE (PROT. GOIM 2601) [J] . F Giuliani, V. Lorusso, F. De Vita European Journal of Cancer Supplements . 2008,第14期

机译：贝伐单抗+福莫瑞作为晚期大肠癌（ACC）的一线治疗：GRUPPO ONCOLOGICO DELL ITALIA MERIDIONALE（PROT。GOIM 2601）的多中心II期研究
3. Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. GOIM 2601) [J] . F. Giuliani, V. Lorusso, F. De Vita, European Journal of Cancer Supplements . 2008,第14期

机译：贝伐单抗+氟替利作为晚期结直肠癌（ACC）的一线治疗：Gruppo Oncologico dell'Italia Meridionale（prot。GOIM 2601）的多中心II期研究
4. Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell' Italia Meridionale (prot. GOIM 2601) [J] . F. Giuliani, V. Lorusso, F. De Vita, European Journal of Cancer Supplements . 2008,第14期

机译：贝伐单抗+氟替利作为晚期结直肠癌（ACC）的一线治疗：Gruppo Oncologico dell'Italia Meridionale（prot。GOIM 2601）的多中心II期研究
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study [O] . P. Vici, M. Brandi, F. Giotta, -1

机译：高剂量表柔比星联合环磷酰胺（EC）与多西他赛联合EC联合治疗淋巴结阳性乳腺癌的多中心III期前瞻性随机试验。 GOIM（Gruppo Oncologico Italia Meridionale）9902研究
7. Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601) [O] . Giuliani F., Lorusso V., De Vita F., 2008

机译：贝伐单抗+氟替利作为晚期大肠癌（ACC）的一线治疗：Gruppo Oncologico dell’Italia Meridionale（prot。GOIM 2601）的多中心II期研究

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell’Italia Meridionale (GOIM 2802)

著录项

引文网络

相似文献

相关主题

期刊订阅